SPONSOR
Chipscreen Biosciences, Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Chipscreen Biosciences, Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Small Cell Lung Cancer, Advanced Solid Malignant Tumor.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chipscreen Biosciences, Ltd.
How many clinical trials has Chipscreen Biosciences, Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Chipscreen Biosciences, Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Small Cell Lung Cancer, Advanced Solid Malignant Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chipscreen Biosciences, Ltd. research focus on?
Chipscreen Biosciences, Ltd. clinical trials span Small Cell Lung Cancer, Advanced Solid Malignant Tumor. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chipscreen Biosciences, Ltd. clinical trial?
To participate in a Chipscreen Biosciences, Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chipscreen Biosciences, Ltd. trials with current recruitment status updated daily.
Clinical Trials by Chipscreen Biosciences, Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology